Structure Therapeutics (NASDAQ:GPCR) Shares Gap Up to $23.67

Structure Therapeutics Inc. (NASDAQ:GPCR – Get Rating) shares gapped up prior to trading on Friday . The stock had previously closed at $23.67, but opened at $24.31. Structure Therapeutics shares last traded at $24.38, with a volume of 1,934 shares changing hands.

Analysts Set New Price Targets

A number of research analysts have recently commented on the company. SVB Securities assumed coverage on Structure Therapeutics in a research note on Tuesday, February 28th. They issued an “outperform” rating and a $33.00 price target for the company. BMO Capital Markets assumed coverage on Structure Therapeutics in a research note on Tuesday, February 28th. They issued an “outperform” rating and a $40.00 price target for the company. Guggenheim assumed coverage on Structure Therapeutics in a research note on Tuesday, February 28th. They issued a “buy” rating and a $50.00 price target for the company. Jefferies Financial Group assumed coverage on Structure Therapeutics in a research note on Tuesday, February 28th. They issued a “buy” rating and a $34.00 price target for the company. Finally, SVB Leerink reiterated an “outperform” rating on shares of Structure Therapeutics in a research note on Tuesday, February 28th. Five analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of “Buy” and a consensus target price of $39.25.

Structure Therapeutics Trading Down 0.5 %

About Structure Therapeutics

(Get Rating)

Structure Therapeutics Inc is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc is based in SAN FRANCISCO.